▶ 調査レポート

診断用放射性医薬品&造影剤の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。診断用放射性医薬品&造影剤の世界市場 2020年:企業別、地域別、種類・用途別 / Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00284資料のイメージです。• レポートコード:D005-00284
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、診断用放射性医薬品&造影剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。診断用放射性医薬品&造影剤の種類別市場規模(放射性医薬品、造影剤)、用途別市場規模(診断、治療、電離放射線系放射線画像、非電離放射線系放射線画像)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Amag Pharmaceuticals、Mallinckrodt、Daiichi Sankyo、Bayer Healthcare、Lantheus、Bracco Imaging、Nordion、Guerbet、GE Healthcare、Medtronic
・地域別グローバル市場分析 2015年-2020年
・診断用放射性医薬品&造影剤の北米市場(アメリカ、カナダ、メキシコ)
・診断用放射性医薬品&造影剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・診断用放射性医薬品&造影剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・診断用放射性医薬品&造影剤の南米市場(ブラジル、アルゼンチン)
・診断用放射性医薬品&造影剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:放射性医薬品、造影剤
・用途別分析:診断、治療、電離放射線系放射線画像、非電離放射線系放射線画像
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9594.6 million by 2025, from USD 8567.7 million in 2019.

The Diagnostic Radiopharmaceuticals & Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Diagnostic Radiopharmaceuticals & Contrast Media market has been segmented into:
Radiopharmaceuticals
Contrast Media

By Application, Diagnostic Radiopharmaceuticals & Contrast Media has been segmented into:
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Radiopharmaceuticals & Contrast Media market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Radiopharmaceuticals & Contrast Media markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Radiopharmaceuticals & Contrast Media market.

The report offers in-depth assessment of the growth and other aspects of the Diagnostic Radiopharmaceuticals & Contrast Media market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Diagnostic Radiopharmaceuticals & Contrast Media Market Share Analysis
Diagnostic Radiopharmaceuticals & Contrast Media competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Radiopharmaceuticals & Contrast Media sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Radiopharmaceuticals & Contrast Media sales, revenue and market share for each player covered in this report.

The major players covered in Diagnostic Radiopharmaceuticals & Contrast Media are:
Amag Pharmaceuticals
Mallinckrodt
Daiichi Sankyo
Bayer Healthcare
Lantheus
Bracco Imaging
Nordion
Guerbet
GE Healthcare
Medtronic

レポート目次

Table of Contents

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Classification of Diagnostic Radiopharmaceuticals & Contrast Media by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type in 2019
1.2.3 Radiopharmaceuticals
1.2.4 Contrast Media
1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Application
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic
1.3.3 Therapeutic
1.3.4 Ionizing Radiation based Radioimaging
1.3.5 Non-Ionizing Radiation based Radioimaging
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Regions
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnostic Radiopharmaceuticals & Contrast Media (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amag Pharmaceuticals
2.1.1 Amag Pharmaceuticals Details
2.1.2 Amag Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amag Pharmaceuticals SWOT Analysis
2.1.4 Amag Pharmaceuticals Product and Services
2.1.5 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mallinckrodt SWOT Analysis
2.2.4 Mallinckrodt Product and Services
2.2.5 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Daiichi Sankyo SWOT Analysis
2.3.4 Daiichi Sankyo Product and Services
2.3.5 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Healthcare
2.4.1 Bayer Healthcare Details
2.4.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Healthcare SWOT Analysis
2.4.4 Bayer Healthcare Product and Services
2.4.5 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lantheus
2.5.1 Lantheus Details
2.5.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Lantheus SWOT Analysis
2.5.4 Lantheus Product and Services
2.5.5 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bracco Imaging
2.6.1 Bracco Imaging Details
2.6.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bracco Imaging SWOT Analysis
2.6.4 Bracco Imaging Product and Services
2.6.5 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nordion SWOT Analysis
2.7.4 Nordion Product and Services
2.7.5 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.8 Guerbet
2.8.1 Guerbet Details
2.8.2 Guerbet Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Guerbet SWOT Analysis
2.8.4 Guerbet Product and Services
2.8.5 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.9 GE Healthcare
2.9.1 GE Healthcare Details
2.9.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GE Healthcare SWOT Analysis
2.9.4 GE Healthcare Product and Services
2.9.5 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
2.10 Medtronic
2.10.1 Medtronic Details
2.10.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Medtronic SWOT Analysis
2.10.4 Medtronic Product and Services
2.10.5 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
3.2.2 Top 10 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Regions
4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
5.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
5.2 USA Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
6.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
6.2 Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.3 UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.4 France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
7.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
7.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.5 India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
8 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries
8.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
8.2 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnostic Radiopharmaceuticals & Contrast Media by Countries
9.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Type (2019-2024)
10.3 Radiopharmaceuticals Revenue Growth Rate (2015-2025)
10.4 Contrast Media Revenue Growth Rate (2015-2025)
11 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Segment by Application
11.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2015-2020)
11.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Application (2019-2024)
11.3 Diagnostic Revenue Growth (2015-2020)
11.4 Therapeutic Revenue Growth (2015-2020)
11.5 Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)
11.6 Non-Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)
12 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)
12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)
12.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Regions (2021-2025)
12.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.6 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amag Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 7. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 8. Amag Pharmaceuticals SWOT Analysis
Table 9. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 10. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mallinckrodt Corporate Information, Location and Competitors
Table 12. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 13. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2018-2019)
Table 14. Mallinckrodt SWOT Analysis
Table 15. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 16. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Daiichi Sankyo Corporate Information, Location and Competitors
Table 18. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 19. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 20. Daiichi Sankyo SWOT Analysis
Table 21. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 22. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Healthcare Corporate Information, Location and Competitors
Table 24. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 25. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 26. Bayer Healthcare SWOT Analysis
Table 27. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 28. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Lantheus Corporate Information, Location and Competitors
Table 30. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 31. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 32. Lantheus SWOT Analysis
Table 33. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 34. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bracco Imaging Corporate Information, Location and Competitors
Table 36. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 37. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 38. Bracco Imaging SWOT Analysis
Table 39. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 40. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Nordion Corporate Information, Location and Competitors
Table 42. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 43. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 44. Nordion SWOT Analysis
Table 45. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 46. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Guerbet Corporate Information, Location and Competitors
Table 48. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 49. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 50. Guerbet SWOT Analysis
Table 51. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 52. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GE Healthcare Corporate Information, Location and Competitors
Table 54. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 55. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 56. GE Healthcare SWOT Analysis
Table 57. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 58. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Medtronic Corporate Information, Location and Competitors
Table 60. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Major Business
Table 61. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Total Revenue (USD Million) (2017-2018)
Table 62. Medtronic SWOT Analysis
Table 63. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product and Solutions
Table 64. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Players (2015-2020)
Table 66. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Players (2015-2020)
Table 67. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions (2015-2020)
Table 69. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
Table 70. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 71. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
Table 74. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Table 77. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) by Type (2015-2020)
Table 78. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2015-2020)
Table 79. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2021-2025)
Table 80. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2015-2020)
Table 81. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2015-2020)
Table 82. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2021-2025)
Table 83. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Picture
Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type in 2019
Figure 3. Radiopharmaceuticals Picture
Figure 4. Contrast Media Picture
Figure 5. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application in 2019
Figure 6. Diagnostic Picture
Figure 7. Therapeutic Picture
Figure 8. Ionizing Radiation based Radioimaging Picture
Figure 9. Non-Ionizing Radiation based Radioimaging Picture
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share in 2019
Figure 19. Global Top 10 Players Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions (2015-2020)
Figure 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Regions in 2018
Figure 24. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 25. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 27. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 29. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 30. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 31. USA Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 32. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 34. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 36. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 37. UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 38. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 39. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 40. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 43. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 44. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 45. Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 46. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 48. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 49. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 50. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 55. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
Figure 58. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2015-2020)
Figure 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type in 2019
Figure 60. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Type (2021-2025)
Figure 61. Global Radiopharmaceuticals Revenue Growth Rate (2015-2020)
Figure 62. Global Contrast Media Revenue Growth Rate (2015-2020)
Figure 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2015-2020)
Figure 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application in 2019
Figure 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share Forecast by Application (2021-2025)
Figure 66. Global Diagnostic Revenue Growth Rate (2015-2020)
Figure 67. Global Therapeutic Revenue Growth Rate (2015-2020)
Figure 68. Global Ionizing Radiation based Radioimaging Revenue Growth Rate (2015-2020)
Figure 69. Global Non-Ionizing Radiation based Radioimaging Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 74. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 76. South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel